CATALYST DOSSIER · UPDATED 2026-11-20
$WORX
tech · convergence 9 · conviction WATCH
Price & Live Quote Loading live quote & chart…
Practice trade tools Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.
Paper trade unavailable: missing risk-bounded frame
Reference only. Not financial advice. No brokerage order is placed.
Why $WORX?
Quantitative
Revenue (CY2026Q2) : $706.0K (+343.0% YoY)
Net Income (CY2026Q2) : $-121.0K (+93.7% YoY)
Catalysts
Multi-spoke convergence : 11 convergent signals fired: earnings, regsho, xbrl_ni, pill, orderbook
Risks
Hard-to-borrow / FTD risk : Borrow rate 6.0%, distress score 30
Reg SHO threshold list : On NASDAQ threshold list (2026-11-19)
Late filing (NT) : Filed Form NT — accounting / control concern
Bear case
Earnings binary : Print-day moves can swing ±15% — gap risk both directions
Sympathy basket (cerebro)
BZAI via semis r=+0.95 sympathetic (score 4)
FLEX via semis r=+0.95 sympathetic (score 4)
MMED via biotech r=+0.67 sympathetic (score 20)
CTGO via biotech r=+0.67 sympathetic (score 18)
RSVR via consumer r=+0.66 sympathetic (score 16)
DBGI via consumer r=+0.66 sympathetic (score 14)
Signals Firing
earnings regsho xbrl_ni pill orderbook auto_earnings_calendar auto_regsho_threshold auto_macro_adp_payrolls auto_macro_bls_employment auto_macro_credit_spreads auto_macro_durable_goods
Pick Track Record Date List Next-day max run Next-day close Hit +2%? 2026-09-23 sec_top_gappers +34.6% +34.6% ✓ hit 2026-09-23 sec_top_moat_emerging +34.6% +34.6% ✓ hit 2026-09-22 sec_clean_gappers +0.5% -0.2% — 2026-09-22 sec_top_gappers +0.5% -0.2% — 2026-09-22 sec_top_moat_emerging +0.5% -0.2% —
Lifetime: 2/5 wins · hit-rate 40.0% on +2% intraday
Sympathy Basket BZAI via semis · score 4 FLEX via semis · score 4 MMED via biotech · score 20 CTGO via biotech · score 18 RSVR via consumer · score 16 DBGI via consumer · score 14
Earnings Catalyst No recent earnings event.
Generate full earnings report
Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks
and its losses — see the
trust report and
methodology .
Not financial advice. Confirm independently before trading.